These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7602466)

  • 21. The use of an in vitro dissolution and absorption system to evaluate oral absorption of two weak bases in pH-independent controlled-release formulations.
    Sugawara M; Kadomura S; He X; Takekuma Y; Kohri N; Miyazaki K
    Eur J Pharm Sci; 2005 Sep; 26(1):1-8. PubMed ID: 15961297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of diethyl-beta-cyclodextrin on the release of nitroglycerin from formulations.
    Umemura M; Ueda H; Tomono K; Nagai T
    Drug Des Deliv; 1990 Oct; 6(4):297-310. PubMed ID: 2128021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Slow-release of famotidine from tablets consisting of chitosan/sulfobutyl ether β-cyclodextrin composites.
    Anraku M; Hiraga A; Iohara D; Pipkin JD; Uekama K; Hirayama F
    Int J Pharm; 2015 Jun; 487(1-2):142-7. PubMed ID: 25882010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of the physiological variability of fasted gastric pH and tablet retention time on the variability of in vitro dissolution and simulated plasma profiles.
    Kovačič NN; Pišlar M; Ilić I; Mrhar A; Bogataj M
    Int J Pharm; 2014 Oct; 473(1-2):552-9. PubMed ID: 25064726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo correlation for controlled-release formulation of d-chlorpheniramine maleate.
    Katori N; Okudaira K; Aoyagi N; Takeda Y; Uchiyama M
    J Pharmacobiodyn; 1991 Oct; 14(10):567-75. PubMed ID: 1818098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and in vivo evaluation of buccal tablets prepared using danazol-sulfobutylether 7 beta-cyclodextrin (SBE 7) complexes.
    Jain AC; Aungst BJ; Adeyeye MC
    J Pharm Sci; 2002 Jul; 91(7):1659-68. PubMed ID: 12115827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vitro-In Vivo Predictive Dissolution-Permeation-Absorption Dynamics of Highly Permeable Drug Extended-Release Tablets via Drug Dissolution/Absorption Simulating System and pH Alteration.
    Li ZQ; Tian S; Gu H; Wu ZG; Nyagblordzro M; Feng G; He X
    AAPS PharmSciTech; 2018 May; 19(4):1882-1893. PubMed ID: 29663288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Felodipine β-cyclodextrin complex as an active core for time delayed chronotherapeutic treatment of hypertension.
    Pagar KP; Vavia PR
    Acta Pharm; 2012 Nov; 62(3):395-410. PubMed ID: 23470351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-linked β-cyclodextrin and carboxymethyl cellulose hydrogels for controlled drug delivery of acyclovir.
    Malik NS; Ahmad M; Minhas MU
    PLoS One; 2017; 12(2):e0172727. PubMed ID: 28245257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization of diethyl-beta-cyclodextrin as a sustained-release carrier for isosorbide dinitrate.
    Hirayama F; Hirashima N; Abe K; Uekama K; Ijitsu T; Ueno M
    J Pharm Sci; 1988 Mar; 77(3):233-6. PubMed ID: 3373427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclodextrin multicomponent complexation and controlled release delivery strategies to optimize the oral bioavailability of vinpocetine.
    Ribeiro LS; Falcão AC; Patrício JA; Ferreira DC; Veiga FJ
    J Pharm Sci; 2007 Aug; 96(8):2018-28. PubMed ID: 17530626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Synthesis of beta-cyclodextrin polymer beads and its behavior of drug release].
    Wu WJ; Zheng DS; Cai ST; Huang YK
    Zhong Yao Cai; 2007 Mar; 30(3):329-32. PubMed ID: 17634043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery.
    Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM
    Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled release of nifedipine from mucoadhesive tablets of its inclusion complexes with beta-cyclodextrin.
    Chowdary KP; Kamalakara RG
    Pharmazie; 2003 Oct; 58(10):721-4. PubMed ID: 14609284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of microenvironmental pH for dual release and reduced in vivo gastrointestinal bleeding of aceclofenac using hydroxypropyl methylcellulose-based bilayered matrix tablet.
    Kang WH; Nguyen HV; Park C; Choi YW; Lee BJ
    Eur J Pharm Sci; 2017 May; 102():85-93. PubMed ID: 28263912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo and in vitro evaluation of three controlled release principles of 6-N-cyclohexyl-2'-O-methyladenosine.
    Royce A; Li S; Weaver M; Shah U
    J Control Release; 2004 May; 97(1):79-90. PubMed ID: 15147806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimation of agitation intensity in the GI tract in humans and dogs based on in vitro/in vivo correlation.
    Katori N; Aoyagi N; Terao T
    Pharm Res; 1995 Feb; 12(2):237-43. PubMed ID: 7784339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of decrease in both postprandial blood glucose (PBG) and fasting blood glucose (FBG) levels in normal beagle dogs with nateglinide enteric coated granules and immediate release tablets.
    Makino C; Ninomiya N; Sakai H; Orita H; Okano A; Yabuki A
    Chem Pharm Bull (Tokyo); 2006 Apr; 54(4):409-14. PubMed ID: 16595936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro release and in vivo absorption in beagle dogs of meloxicam from Eudragit FS 30 D-coated pellets.
    Gao C; Huang J; Jiao Y; Shan L; Liu Y; Li Y; Mei X
    Int J Pharm; 2006 Sep; 322(1-2):104-12. PubMed ID: 16806752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Coadministered Water on the In Vivo Performance of Oral Formulations Containing N-Acetylcysteine: An In Vitro Approach Using the Dynamic Open Flow-Through Test Apparatus.
    Sager M; Schneider F; Jedamzik P; Wiedmann M; Schremmer E; Koziolek M; Weitschies W
    Mol Pharm; 2017 Dec; 14(12):4272-4280. PubMed ID: 29064257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.